Search Result
Results for "
drug-releasing
" in MedChemExpress (MCE) Product Catalog:
30
Biochemical Assay Reagents
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-42990
-
|
HSPC
|
Liposome
|
Others
|
|
Hydrogenated soya phosphatidylcholines is a natural product. Hydrogenated soya phosphatidylcholines can extend drug release in regard to drug loading and solubility for oral drug delivery of watersoluble drugs .
|
-
-
- HY-144876
-
|
|
Reactive Oxygen Species
|
Cancer
|
|
RIDR-PI-103 is a reactive oxygen species (ROS)-induced drug release prodrug with a self-cyclizing moiety linked to a pan-PI3K inhibitor (PI-103).
|
-
-
- HY-W888521
-
-
-
- HY-167469
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167470
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167471
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167472
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA5000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167473
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167474
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167475
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167476
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA4000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167477
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167478
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167479
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167480
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA3000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167481
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167482
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167483
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167484
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA2000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167485
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167486
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167487
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167488
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA1000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167489
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167490
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167491
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-167492
-
|
|
Biochemical Assay Reagents
|
Others
|
|
PLLA10000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
-
- HY-W250721
-
|
CBM 980
|
Biochemical Assay Reagents
|
Others
|
|
Carbomer 980 (CBM 980) is an acrylic acid polymer, which can be used as a thickening agent. Carbomer 980 provides a stable gel matrix, exhibits good heat, light and microbial contamination resistance. Carbomer 980 facilitates the drug release and local application, which can be used in the pharmaceutical industry .
|
-
-
- HY-W250721B
-
|
CBM 934
|
Biochemical Assay Reagents
|
Others
|
|
Carbomer 934 (CBM 934) is an acrylic acid polymer, which can be used as a thickening agent. Carbomer 934 which forms a high viscosity gel, provides a stable gel matrix, and exhibits good heat, light and microbial contamination resistance. Carbomer 934 facilitates the drug release and local application, which can be used in the pharmaceutical industry .
|
-
-
- HY-W250721C
-
|
CBM 941
|
Biochemical Assay Reagents
|
Others
|
|
Carbomer 941 (CBM 941) is an acrylic acid polymer, which can be used as a thickening agent. Carbomer 941 which forms a high viscosity gel, provides a stable gel matrix, and exhibits good heat, light and microbial contamination resistance. Carbomer 941 facilitates the drug release and local application, which can be used in the pharmaceutical industry .
|
-
-
- HY-W250721A
-
|
CBM 940
|
Biochemical Assay Reagents
|
Others
|
|
Carbomer 940 (CBM 940) is an acrylic acid polymer, which can be used as a thickening agent. Carbomer 940 provides a stable gel matrix, and exhibits good heat, light and microbial contamination resistance. Carbomer 940 shows high benzene content, which exists the risk as a carcinogen. Carbomer 940 facilitates the drug release and local application, which can be used in the pharmaceutical industry .
|
-
-
- HY-156829
-
|
|
Others
|
Cancer
|
|
PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) is a matrix materia, with lactic acid (LA)：glycolic acid (GA) = 1:1, that acts as anti-cancer drug delivery. PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) can improve a drug's bioavailability, efficacy, water solubility, drug encapsulation efficiency, sustained drug release, and to minimize undesirable toxicity .
|
-
-
- HY-156829A
-
|
|
Others
|
Cancer
|
|
PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1) is a matrix materia, with lactic acid (LA)：glycolic acid (GA) = 15:1, that acts as anti-cancer drug delivery. PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1) can improve a drug's bioavailability, efficacy, water solubility, drug encapsulation efficiency, sustained drug release, and to minimize undesirable toxicity .
|
-
-
- HY-158224
-
|
FibMA
|
Biochemical Assay Reagents
|
Others
|
Silk Fibroin Methacryloyl (FibMA) is methacrylated silk fibroin with excellent biocompatibility, stable mechanical properties and good processing properties, and was selected as the substrate for multifunctional microneedle (MN) patches. . MN patches made of Silk Fibroin Methacryloyl exhibit excellent biocompatibility, sustained drug release, pro-angiogenic, antioxidant and antibacterial properties depending on the specific drug encapsulated . Silk Fibroin Methacryloyl needs to self-assemble into fibrous hydrogel under the action of photoinitiator LAP (HY-44076), and target bioactive adhesion sites, play an inherent supporting role for tissue cells and biodegradable activity.
Application: cell culture, biological 3D printing, tissue engineering, etc.
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-42990
-
|
HSPC
|
Drug Delivery
|
|
Hydrogenated soya phosphatidylcholines is a natural product. Hydrogenated soya phosphatidylcholines can extend drug release in regard to drug loading and solubility for oral drug delivery of watersoluble drugs .
|
-
- HY-167469
-
|
|
Drug Delivery
|
|
PLLA5000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167470
-
|
|
Drug Delivery
|
|
PLLA5000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167471
-
|
|
Drug Delivery
|
|
PLLA5000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167472
-
|
|
Drug Delivery
|
|
PLLA5000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA5000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167473
-
|
|
Drug Delivery
|
|
PLLA4000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167474
-
|
|
Drug Delivery
|
|
PLLA4000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167475
-
|
|
Drug Delivery
|
|
PLLA4000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167476
-
|
|
Drug Delivery
|
|
PLLA4000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA4000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167477
-
|
|
Drug Delivery
|
|
PLLA3000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167478
-
|
|
Drug Delivery
|
|
PLLA3000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167479
-
|
|
Drug Delivery
|
|
PLLA3000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167480
-
|
|
Drug Delivery
|
|
PLLA3000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA3000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167481
-
|
|
Drug Delivery
|
|
PLLA2000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167482
-
|
|
Drug Delivery
|
|
PLLA2000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167483
-
|
|
Drug Delivery
|
|
PLLA2000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167484
-
|
|
Drug Delivery
|
|
PLLA2000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA2000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167485
-
|
|
Drug Delivery
|
|
PLLA1000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167486
-
|
|
Drug Delivery
|
|
PLLA1000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167487
-
|
|
Drug Delivery
|
|
PLLA1000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167488
-
|
|
Drug Delivery
|
|
PLLA1000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA1000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167489
-
|
|
Drug Delivery
|
|
PLLA10000-PEG5000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG5000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167490
-
|
|
Drug Delivery
|
|
PLLA10000-PEG3000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG3000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167491
-
|
|
Drug Delivery
|
|
PLLA10000-PEG2000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG2000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-167492
-
|
|
Drug Delivery
|
|
PLLA10000-PEG1000-RhB is a terminal rhodamine-labeled polylactic acid derivative. PLLA10000-PEG1000-RhB can be used to label nanomicelles for real-time monitoring of drug release in vivo .
|
-
- HY-W250721
-
|
CBM 980
|
Drug Delivery
|
|
Carbomer 980 (CBM 980) is an acrylic acid polymer, which can be used as a thickening agent. Carbomer 980 provides a stable gel matrix, exhibits good heat, light and microbial contamination resistance. Carbomer 980 facilitates the drug release and local application, which can be used in the pharmaceutical industry .
|
-
- HY-W250721B
-
|
CBM 934
|
Drug Delivery
|
|
Carbomer 934 (CBM 934) is an acrylic acid polymer, which can be used as a thickening agent. Carbomer 934 which forms a high viscosity gel, provides a stable gel matrix, and exhibits good heat, light and microbial contamination resistance. Carbomer 934 facilitates the drug release and local application, which can be used in the pharmaceutical industry .
|
-
- HY-W250721C
-
|
CBM 941
|
Drug Delivery
|
|
Carbomer 941 (CBM 941) is an acrylic acid polymer, which can be used as a thickening agent. Carbomer 941 which forms a high viscosity gel, provides a stable gel matrix, and exhibits good heat, light and microbial contamination resistance. Carbomer 941 facilitates the drug release and local application, which can be used in the pharmaceutical industry .
|
-
- HY-W250721A
-
|
CBM 940
|
Drug Delivery
|
|
Carbomer 940 (CBM 940) is an acrylic acid polymer, which can be used as a thickening agent. Carbomer 940 provides a stable gel matrix, and exhibits good heat, light and microbial contamination resistance. Carbomer 940 shows high benzene content, which exists the risk as a carcinogen. Carbomer 940 facilitates the drug release and local application, which can be used in the pharmaceutical industry .
|
-
- HY-158224
-
|
FibMA
|
3D Bioprinting
|
Silk Fibroin Methacryloyl (FibMA) is methacrylated silk fibroin with excellent biocompatibility, stable mechanical properties and good processing properties, and was selected as the substrate for multifunctional microneedle (MN) patches. . MN patches made of Silk Fibroin Methacryloyl exhibit excellent biocompatibility, sustained drug release, pro-angiogenic, antioxidant and antibacterial properties depending on the specific drug encapsulated . Silk Fibroin Methacryloyl needs to self-assemble into fibrous hydrogel under the action of photoinitiator LAP (HY-44076), and target bioactive adhesion sites, play an inherent supporting role for tissue cells and biodegradable activity.
Application: cell culture, biological 3D printing, tissue engineering, etc.
|
| Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
| Cat. No. |
Product Name |
|
Classification |
-
- HY-42990
-
|
HSPC
|
|
Phospholipids
|
|
Hydrogenated soya phosphatidylcholines is a natural product. Hydrogenated soya phosphatidylcholines can extend drug release in regard to drug loading and solubility for oral drug delivery of watersoluble drugs .
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent:
